News

SER
Invesco QQQ Trust, Series 1 News

This news view pulls recent coverage and headlines tied to SER.

Latest Close

$2.22

1y Change

-$2.87 (-56.39%)

Market Cap

$56,389,048.00

Sector

Healthcare

Industry

Biotechnology

Recommendation

strong_buy

Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire • Sep 10, 2026

Read article

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

GlobeNewswire • Sep 9, 2026

Read article

Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates

GlobeNewswire • Aug 13, 2026

Read article

Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

GlobeNewswire • Jul 24, 2026

Read article

Serina Completes Enrollment, Dosing in First Cohort of Phase 1b Trial in Parkinson's Disease

MT Newswires • Jul 23, 2026

Read article

Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease

GlobeNewswire • Jul 23, 2026

Read article